ISSN 1662-4009 (online)

ey0017.10-11 | (1) | ESPEYB17

10.11. Screening for retinopathy in children with type 1 diabetes in Denmark

CW Herskin , BS Olsen , M Madsen , P Kjaersgaard , S Fredheim , A Johansen , K Kristensen , NH Birkebaek , J Svensson , KA Pilgaard , J Johannesen

To read the full abstract: Pediatr Diabetes. 2020 Feb;21(1):106–111. doi: 10.1111/pedi.12936. PMID: 31618523Children with type 1 diabetes (T1DM) should be screened regularly for signs of retinopathy by fundus photography in order to prevent visual impairment. According to Danish national guidelines, screening should take place at ages 12, 15, and 18 years after a minimum of 3 years of diab...

ey0017.13-3 | Advocacy, History and Society | ESPEYB17

13.3. Effective coverage measurement in maternal, newborn, child, and adolescent health and nutrition: Progress, future prospects, and implications for quality health systems

AD Marsh , M Muzigaba , T Diaz , J Requejo , D Jackson , D Chou , J Cresswell A , R Guthold , A Moran C , K Strong L , A Banerjee , A Soucat

To read the full abstract: Lancet Glob Health 2020; 8: e730–36. doi: 10.1016/S2214-109X(20)30104-2• Sustainable Development Goals (SDG) were adopted by United Nations Member States in 2015. Universal health coverage is at the centre of SDG #3 but lacks metrics that make it possible to assess how effective the provided healthcare is.• WHO and UNICEF convened a group of ...

ey0017.13-8 | Diabetes | ESPEYB17

13.8. Diabetic microvascular complications among children and adolescents in northwestern Tanzania: A cross-sectional study

D Msanga , K Reis , N Kayange , R Bakalemwa , B Kidenya , D Hau , C Mwanansao , D Mahamba , S Ottaru , E Kwiyolecha , R Peck

To read the full abstract: Annals of Global Health. 2020; 86(1): 43, 1–8. doi: https://doi.org/10.5334/aogh.2669• The authors assessed the prevalence of diabetic microvascular complications in 155 children and adolescents with Type 1 diabetes in northwestern Tanzania.• They observed poor diabetes control in 69% of the patients and a high rate of diabetic nephropathy (32.9%), retin...

ey0016.1-11 | Basic Science: Single-cell Profiling the Hypothalamus | ESPEYB16

1.11. Molecular, spatial, and functional single-cell profiling of the hypothalamic preoptic region

JR Moffitt , D Bambah-Mukku , SW Eichhorn , E Vaughn , K Shekhar , JD Perez , ND Rubinstein , J Hao , A Regev , C Dulac , X Zhuang

To read the full abstract: Science 2018;362(6416) eaau5324The hypothalamus is a highly complex region, which receives many inputs from several other brain regions and also from the periphery. It is the site of synthesis of many neuropeptides that act as neurotransmitters or via the systemic circulation (in blood). Hypothalamic nuclei are typically defined by their exact anatomical locati...

ey0016.2-6 | Neonatal Diabetes Mellitus | ESPEYB16

2.6. Trisomy 21 is a cause of permanent neonatal diabetes that is autoimmune but not HLA associated

MB Johnson , E De Franco , W Atma , S Greeley , LR Letourneau , K Gillespie , International DS-PNDM consortium , MN Wakeling , S Ellard , SE Flanagan , KA Patel , AT Hattersley

To read the full abstract: Diabetes. 2019 Apr 8. pii: db190045. doi: 10.2337/db19-0045.This study assessed the incidence of permanent neonatal diabetes mellitus (PNDM) in patients with Trisomy 21.Patients with Trisomy 21 have an increased prevalence of autoimmune conditions, such as Type 1 diabetes, celiac disease, alopecia, vitiligo and autoimmune thyroid disorder...

ey0016.3-2 | Thyroid Hormone Action | ESPEYB16

3.2. Thyroid hormone signaling specifies cone subtypes in human retinal organoids

KC Eldred , SE Hadyniak , KA Hussey , B Brenerman , PW Zhang , X Chamling , VM Sluch , DS Welsbie , S Hattar , J Taylor , K Wahlin , DJ Zack , RJ Jr Johnston

To read the full abstract: Science. 2018;362(6411).Here, developmental regulation of deiodinases DIO2 and DIO3 were identified as main regulators of thyroid hormone dependent sequential cone subtype specification in human retinal organoids. Either complete loss of thyroid hormone signaling or non-physiologically high thyroid hormone levels completely suppressed either medium and long wav...

ey0016.3-13 | Graves’ Disease | ESPEYB16

3.13. Adjuvant rituximab, a potential treatment for the young patient with Graves' hyperthyroidism (RiGD): study protocol for a single-arm, single-stage, phase II trial

M Cole , AM Hynes , D Howel , L Hall , M Abinun , A Allahabadia , T Barrett , K Boelaert , AJ Drake , P Dimitri , J Kirk , N Zammitt , S Pearce , T Cheetham

To read the full abstract: BMJ Open. 2019;9:e024705.This protocol paper describes an innovative phase II trial to study the effect of a single low dose of adjuvant rituximab (a chimeric anti-B-cell monoclonal antibody targeting the surface molecule CD20) compared to classical carbimazole therapy in adolescents and young adults with Graves’ disease. Carbimazole treatment will be stop...

ey0016.5-17 | Basic Science - Bone | ESPEYB16

5.17. Coupling of bone resorption and formation by RANKL reverse signalling

Y Ikebuchi , S Aoki , M Honma , M Hayashi , Y Sugamori , M Khan , Y Kariya , G Kato , Y Tabata , JM Penninger , N Udagawa , K Aoki , H Suzuki

Abstract: Nature. 2018 Sep;561(7722):195–200.In brief: This study used various cell-based methods and animal models to investigate the RANK-RANKL signaling pathway in bone homeostasis. The authors show for the first time, that reverse signaling exists from osteoclast to osteoblast and that vesicular RANK, secreted by the osteoclast, relays information to the osteoblast...

ey0016.5-19 | Basic Science - Mineral Metabolism | ESPEYB16

5.19. Eldecalcitol causes FGF23 resistance for Pi reabsorption and improves rachitic bone phenotypes in the male Hyp mouse

I Kaneko , H Segawa , K Ikuta , A Hanazaki , T Fujii , S Tatsumi , S Kido , T Hasegawa , N Amizuka , H Saito , KI Miyamoto

Abstract: Endocrinology, Volume 159, Issue 7, July 2018, Pages 2741–2758In brief: Eldecalcitol, a long acting active vitamin D3 analogue with lower affinity for vitamin D receptor and resistance to inactivation by vitamin D 24-hydroxylase, causes FGF23 resistance. This leads to complete restoration of renal phosphate transport and NaPi-2a protein levels and improves ra...

ey0016.6-1 | DSD New Paradigm | ESPEYB16

6.1. Oestrogen versus androgen in hormone-replacement therapy for complete androgen insensitivity syndrome: a multicentre, randomised, double-dummy, double-blind crossover trial

W Birnbaum , L Marshall , R Werner , A Kulle , PM Holterhus , K Rall , B Kohler , A Richter-Unruh , MF Hartmann , SA Wudy , MK Auer , A Lux , S Kropf , O Hiort

Lancet Diabetes Endocrinol. 2018 Oct;6(10):771–780.doi: 10.1016/S2213-8587(18)30197-9.For the first time a prospective randomized treatment study has been performed for individuals with a DSD. This national multi-center, double-blind, randomized, cross-over trial compared estrogen therapy to androgen replacement in complete androgen insensitivity syndrome ...